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Towards a rational cervical
cytology screening
strategy
Case study of a peri-urban settlement
Ross Bailie, Peter Barron, Genevieve Learmonth
Objectives. To assess cervical cytology screening activity
in a peri-urban settlement near Cape Town, with a view to
informing rational policy development.
Method. Total and age-specific prevalence rates of
women who had been screened, relative prevalence by age
group of women who had not been screened, and yield of
screening were estimated from cytopathology laboratory
records and available demographic data. Age-specific
prevalence rates among women who had been screened
were compared with age at presentation with cervical
cancer at the referral hospital. Attendance for colposcopy
follow-up was assessed from colposcopy clinic records.
Results. The number of smears taken and the
prevalence of women who had been screened peaked in
the 20 - 24-year age group, and declined to low levels in
those over the age of 40 years. The relative prevalence of
those who had not had a smear exceeded 9 in all age
groups over 39 years, compared with women of 20 - 24
years. Smears which showed signs of CIN Ill, malignancy
or possible malignancy comprised 0,13%. Thirty-six per
cent of women booked for colposcopy did not attend.
Conclusions. Efficiency of screening could be improved
by emphasising coverage of higher-risk age groups, e.g.
women over the age of 30 years, and better follow-up.
S Atr Med J 1995; 85: 30-33.
The official policy of the Department of National Health and
Population Development (DNHPD) in respect of cervical
cytology screening is broadly consistent with the
recommendations of working groups in developed countries
such as Canada' and New Zealand! This policy requires
screening at 3-yearly intervals of all women for most of their
adult lives.
The policy is unrealistic and impractical for South Africa.
As a consequence, screening practice is largely
opportunistic. As in other countries:-7 many women are
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screened, but they tend to be those at relatively low risk and
may be screened more frequently than necessary." This
results in consumption of resources which could be better
spent on a rational screening programme which includes the
high-risk groupS.7,9
Despite evidence of the effectiveness of organised
cervical cytology screening programmes, and repeated calls
in the local medical literature, '0-'3 South African medical
services have failed to develop a rational screening policy.'·
The aim of this study was to examine screening activity in
Khayelitsha, a defined peri-urban settlement near Cape
Town, over a 5-year period (1988 - 1992), with a view to
informing the development of a rational screening policy.
Khayelitsha is the largest black urban residential area in
the Western Cape, having been established in 1983. It has
predominantly informal housing. In early 1992 the population
was estimated to be between 300 000 and 350 000
(W. Lombard, Western Cape Regional Services Council -
personal communication). Cervical cytology screening is_
carried out almost exclusively by family planning and
maternity services, while the two day hospitals, which arr
responsible for general curative services, do very little
screening.
Method
Data on cervical smears were obtained from the
computerised records of Groote Schuur Hospital
Cytopathology Laboratory. This laboratory processed all
smears taken by public health services in Khayelitsha over
the 5-year period. Total and age-specific prevalences of
women who had a cervical smear were calculated for the
period 1988 - 1992. The numerators for the calculations
were the number of cervical smears taken within specific
age groups. The denominator used was the 1991
demographic data from a report by Harrison and McQueen.15
The resulting screening prevalence rates assume that each
woman had at most one smear in the 5-year period. These
rates therefore represent the maximum possible 5-year
screening prevalence rates.
With the 5-year screening prevalence in the 20 - 24-year
age group used as a reference, the relative prevalences of
not having had a smear for women in other age groups were
calculated, with 95% confidence intervals, using the Epi Info
computer package.
The yield of screening was determined by diViding of the
number of smears which showed signs of CIN Ill,
malignancy or possible malignancy, by the total number of
smears taken. (Only women with smears showing CIN III or
more severe abnormalities are referred for colposcopy.)
The extent of successful follow-up was measured by
determining the proportion of women whose smears showed
signs of CIN Ill, who actually attended for assessment at the
colposcopy clinic. Records of attendance were obtained
from Groote Schuur Hospital's colposcopy clinic.
The maximum number of smears which each woman in
the community could have had in the 5-year period, given
uniform coverage and at current screening levels, was
estimated by dividing the total number of smears done by
the total number of women aged 15 years or more. The
inverse of this number was then multiplied by 5 years to give
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an estimate, in years, of the period during which each
woman could have been screened once under these
hypothetical conditions.
The age distribution for screening was compared with the
distribution of age at presentation with cervical carcinoma at
Groote Schuur Hospital. Data on age at presentation were
obtained by reviewing the records of all women who
presented with cervical cancer for the first time in 1991.
Khayelitsha was 29 739. Given uniform coverage, this would
indicate that approximately 1 woman in 4 had had a smear
in the 5-year period of this study. Or, given the hypothetical
situation where all other factors remained constant, it would
allow each woman to be screened once every 20 years.
Table 11. Relative prevalence of not having had a smear by
5-year age group, using the 20 - 24-year age group as reference,
1988 - 1992
Age Relative prevalence 95% confidence interval
Results
Information on the number of smears done relative to age
group, the number showing signs of CIN Ill, and the number
showing signs of malignancy or possible malignancy, the
estimated number of women in the community in each age
group, and the number of smears done per 1 000 women, is
shown in Table I.
Table I. Number of smears (total and abnormal) and number of

































Smears per 1000 women Age at presentation with cancer (percent)
~ ~
Follow-up at colposcopy
Of the 36 women whose smears showed signs of CIN 111,23
had attended for assessment at the colposcopy clinic. This
represents a follow-up rate of 64%.
Yield
In the 5-year period 1988 - 1992, 36 smears showed signs
of CIN Ill, 2 showed signs of malignancy, and 2 the
possibility of malignancy. The yield was thus 0,13%. In other








Fig. 1. Smears per 1 000 women by age group v. age at
presentation with cervical cancer.
Age at presentation with
cervical cancer
The distribution of age at presentation with cervical
carcinoma at Groote Schuur Hospital in 1991 is shown in
Fig. 1. There is a steady increase in the number of cases
(N = 131) to a peak in the 50 - 54-year age group, with a
slight decline in the older age groups. Over 80% of patients
presented at 40 years or older. The age distribution of
smears per 1 000 women is superimposed.
No. of
Malignant! No. of smears/
Age No. of possibly women 1 000
(yrs) smears CIN III malignant (1991) women
15 - 19 5667 1 0 20000 283
20 - 24 9726 6 1 19678 494
25 - 29 7102 11 0 19400 366
30 - 34 4302 3 0 18504 232
35 - 39 1 901 7 0 14776 129
40 - 44 511 3 0 9500 54
45 - 49 229 1 0 6000 38
50 - 54 120 1 1 3505 34
55 - 59 73 2 1 2090 35
60 - 64 37 1 0 2000 19
65+ 71 0 1 1 865 38
-- - - --- -
Total 29739 36 4 117 318 253
Maximum possible coverage under
current conditions
The total number of women aged 15 years and over was
estimated to be 117 318. 15 The total number of smears
recorded by the cytopathology laboratory as coming from
The number of smears taken, as well as the number of
smears per 1 000 women (Le. the maximum possible 5-year
screening prevalence), peaked in the 20 - 24-year age group
and then steadily declined in each successive older group.
The likelihood of being screened
relative to age
The relative 5-year prevalences of women who had not had
a smear in different age groups, compared with women in
the 20 - 24-year age group, are shown in Table 11. The
relative prevalence of women over the age of 24 years who
had not had a smear rises rapidly, and exceeds 10 for all
age categories over 45 years. Teenagers have a lower
relative prevalence of not being screened than women aged
30 years and older. In other words, proportionately more
teenagers aged 15 - 19 years had had a cervical smear
taken than women of 30 years or older.
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Discussion
Limitations
This study is limited by the crudeness of the data used, both
for the numerator and the denominator. For the numerator,
the estimates made of screening frequency were based on
the assumption that each woman who was screened in this
period had only one smear. It is highly likely that some
women were screened more than once during the 5-year
period. The screening frequency estimates are therefore a
'best scenario'. This implies that the true screening
frequency of the number of individual women who had been
screened would be lower (i.e. the interval between smears
would be longer than 20 years).
Furthermore, the possibility of women being screened at
services outside Khayelitsha may have led to an artificially
low figure for the number of smears recorded in this
community. However, the number of such women is
believed to be small, given very low employment levels, and
thus little reason or limited resources for travel outside
Khayelitsha.
The accuracy of the relative prevalence estimates
assumes that the proportion of women who are rescreened
are similar in both the age group of interest and the
reference group. This study does not provide information as
to whether this is the case or not. However, the magnitude
of the relative prevalence estimates indicates that there is a
real difference in the likelihood that women in the different
groups have been screened, even if the estimated size of
the difference is imprecise.
Demographic data for black people in this country are
notoriously poor. The data used in this study are the best
available estimates. The estimates of the number of smears
per woman (and the likelihood of being screened) are
therefore crude. However, the magnitude of the differences
indicates that the differences are real, although not precise.
The comparison of the number of smears per woman in
the different groups would be affected by inaccuracies in the
estimate of the age distribution within the population, and
not simply by inaccuracies in the estimation of the total
number of women. Here again the magnitudeof the
difference between age groups in the number of smears per
woman indicates that the differences are real.
Cervical carcinoma in context
Although cervical carcinoma is the most important cause of
cancer mortality in black women in South Africa," this
disease should be viewed against the background of the
general health status of people living in communities such
as Khayelitsha. Many other preventable causes of mortality
and morbidity have a greater impact on the health status of
the community.'s A cervical can.cer control programme in
Khayelitsha must therefore compete for scarce resources
with a number of other programmes of proven effectiveness.
Screening interval
It has been proposed that all women be screened once over
the next 5 years.'· Assuming uniform coverage can be
achieved, the findings of this study indicate that in order to
screen each woman once over the next 5 years, screening
services would have to be increased at least fourfold in this
community. As it is unlikely that there was uniform coverage,
a more than fourfold increase in services is needed. Given
the other health service needs in this community and the
resource constraints, the proposal is impracticable.
The likelihood of being screened
relative to age
The findings indicate that women in the age groups at which
premalignant lesions are most likely to occur are
considerably less likely to be screened than those in the
younger low-risk age groups of the population. This is
clearly highlighted in Fig. 1, and represents a grossly
inefficient use of resources.
It can be seen that the peak in the number of smears per
woman occurs at an age approximately 30 years younger
than the peak age at presentation for cervical cancer. Given
the 10 - 15-year period for progression from GIN III to
invasive cancer,""· the vast majority of women who are'
going to develop cancer will be missed if women are not
screened at an older age than most of the women screened
in the period of this study. Infiltrating cancer of the cervix is
predominantly a disease of middle-aged and older women.
Over 75% of patients who present at Groote Schuur
Hospital are over the age of 39 years (Fig. 1). A screening
programme concentrating on women over the age of 30
years would therefore produce an increased yield.
Yield, follow-up and number of cancers
prevented
The yield of screening, as measured by the number of
smears which required follow-up ('positive smears'), in
relation to the total number of smears processed at the
laboratory, is an overestimate of the true yield. The true yield
should be based on the number of women with GIN III who
are successfUlly followed up and attended for further
investigation of the condition.
The proportion of women with 'positive smears' who were
successfully followed up in the period of this study was
0,64. Thus, the true yield is approximately 0,08, or 8/10 000.
Assuming that 50% of cases of GIN III progress to invasive
cancer," this would lead to the prevention of 4 cases of
invasive cancer for every 10 000 smears taken. Thus the
29 739 smears taken over the 5-year period are estimated
to have prevented the development of invasive cancer in 12
women, assuming all cases of GIN III were effectively
treated.
The yield and rate of successful follow-up of abnormal
cases have important implications for cost-effectiveness of
the programme.
Conclus·ion
It is clear that the control of cervical cancer in Khayelitsha
could be improved through the development of an organised
screening programme by using the existing capacity in a
more effiCient manner. This study shows a marked
discrepancy between need, in terms of age-related risk of
cervical cancer, and the experience of women in obtaining
cervical smears. Screening of predominantly young,
relatively low-risk women results'in a low yield and
•
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consequent inefficiency. This inefficiency is compounded by
poor success in following up women with abnormal smears.
To be effective, a screening programme should aim to
maximise coverage through a systematic and efficient
process, rather than increase the frequency of screening."
WHO recommendations for developing countries are to aim
initially to screen every woman once in her lifetime at the
age of about 40 years." With greater resources the
frequency of screening may be increased to once every 10
years, and then to once every 5 years for women between
the ages of 35 and 55 years."
The level of resources currently expended on screening in
Khayelitsha indicates that services should aim initially to
screen each woman once in her lifetime. This strategy's
increased yield, through maximisation of coverage, will result
in greater cost-effectiveness than the provision of repeat
smears to a smaller number of women in order to improve
the sensitivity of cytology screening. The distribution of age
at presentation indicates that this screening should take
place between 35 and 40 years of age. Measures to improve
follow-up should be emphasised. The basic principles of
primary health care (accessibility, acceptability, availability,
affordability) should be applied in the quest to achieve
maximum coverage, which is the first major target. Improved
coverage of higher-risk groups has major implications for the
organisation and provision of primary care services in similar
settings throughout South Africa.
We thank Shona Wilson for extracting the data for this study,
and Professor Jonny Myers and Or Leslie London for reviewing
early drafts of the article.
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A report on the status quo
H. W. Hitzeroth, C. E. Niehaus, D. C. Brill
During the 1980s a pilot newborn screening programme
for the early detection (and treatment) of amino
acidopathies, especially phenylketonuria (PKU), was
conducted by the Department of National Health and
Population Development. The motivation for this pilot
programme was the high priority accorded PKU screening
in Europe and North America and the presumed similarly
high incidence of this condition among South Africans of
European origin. From a cohort of 59 600 newborns
screened in the Pretoria area over a period of 8
consecutive years (1979 - 1986), only 1 case of PKU (and
1 of tyrosinaemia) was found. Statistically this result is
compatible (Poisson distribution, 95% confidence interval)
with a 'true' incidence of not more than 3/59 600 (or about
1/20000) newborns. It is concluded from this result and
other relevant information that newborn screening for PKU
and other amino acidopathies is not cost-effective and
justifiable, especially against the background of prevailing
demographic conditions and more pressing health
priorities in South Africa. This particular screening
programme was discontinued in 1986. The results and
conclusions are presented here. for the record.
S Afr Med J 1995; 85: 33-36.
Phenylketonuria (PKU) is a well-known, inherited metabolic
disease. It has attained a high profile in the context of
medicogenetic preventive services: because, among other
reasons, it is known to cause severe and irreversible mental
retardation;'·2 its incidence among newborns in western
Europe and North America is such that it warrants
interventional programmes (fable I); it can be diagnosed pre-
clinically by means of neonatal screening and subsequent
specific laboratory tests;,,3-5 and its serious sequelae,
including mental retardation, are preventable by early dietary
treatment'·· Before the advent of newborn screening
programmes for the prevention of PKU, relatively high
numbers of patients in centres for the mentally handicapped
owed their institutionalisation to this genetic disease.'-9
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